TScan Therapeutics, Inc. Common Stock
$0.34
▼ 0.01
(-2.58%)
Volume: 381,047
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -56.3%
- MA aligned bearish
- RSI 30 oversold
🎯
Pullback
55
- RSI 30 near lows
- -15.0% vs 20MA
💎
Value
58
- -87% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)29.6
MACD+0.014
MA trendBearish
ATR13.35%
21d mom.-56.3%
63d mom.-64.9%
vs 20MA-15.0%
RVOL(20)0.28×
52w low · 0
52w high · 3
-86.8% from 52-week high
20d support 0
· resistance 1
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$24M
PER—
PBR0.34
PSR3.34
EPS$-1.74
ROE-170.6%
ROA-68.7%
Dividend yield0.00%
Debt/Equity0.47
EV/EBITDA0.37
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +9.01% | -56.26% | -64.91% | -66.99% | -81.52% | -66.67% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -13.15%, daily vol 8.98%. TScan Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.